Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,582.69
(
0.11%
)
US TECH 100
23,544.40
(
0.62%
)
Dow Jones
46,504.67
(
-0.13%
)
Brent Oil
105.75
(
-3.14%
)
Bitcoin
69,246.24
(
0.34%
)
News Focus
News Focus
Post# of 2799
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BlazingStocks

Send PM Follow Ignore
Followers 166
Posts 42051
Boards Moderated 4
Alias Born 10/20/2019

BlazingStocks

Re: TacoTuesdayz post# 2543

Tuesday, 10/04/2022 8:32:37 AM

Tuesday, October 04, 2022 8:32:37 AM

Post# of 2799
Looking forward to completing this cohort and moving to Phase II. $NBIO

Sean Carrick, Nascent CEO, explains, "We are enthusiastically encouraging anyone interested in screening for the trial to do so in a timely manner. This cohort of patients will likely be the final one in this trial, and new patient enrollment will cease until our Phase II research gets underway."
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote